Timken (TKR) Tops Q2 EPS by 68c
Tweet
Share
E-mailGet Alerts TKR Hot Sheet
Price: $133.50 --0%
Financial Fact:
Cost of products sold: 489.9M
Today's EPS Names:
LUNA, BTTX, VAXX, More
Financial Fact:
Cost of products sold: 489.9M
Today's EPS Names:
LUNA, BTTX, VAXX, More
Join SI Premium – FREE
Timken (NYSE: TKR) reported Q2 EPS of $1.02, $0.68 better than the analyst estimate of $0.34. Revenue for the quarter came in at $804 million versus the consensus estimate of $722.13 million.
Given the continued uncertainty surrounding COVID-19, the company is not providing full year 2020 sales and earnings guidance at this time.
For earnings history and earnings-related data on Timken (TKR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- LeonaBio (LONA) Price Target Cut to $17 by Citizens Amid Pipeline Development
- Movano (MOVE) Misses Q2 EPS by 195c
- Keefe, Bruyette & Woods Downgrades Bain Capital Specialty Finance (BCSF) to Market Perform
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
